Securities Purchase AgreementSecurities Purchase Agreement • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 21st, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (the “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledMay 21st, 2024 Company IndustryThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
Omnibus Waiver, Consent, Notice and AmendmentConsent and Amendment • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledMay 21st, 2024 Company IndustryThis Omnibus Waiver, Consent and Amendment (this “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).